Hostname: page-component-66d9dcfd78-qkmwt Total loading time: 0 Render date: 2026-08-08T21:04:37.860Z Has data issue: false hasContentIssue false
  • English
  • Français

Orphan Drug Designation and Exclusivity for “Same Drugs”

Published online by Cambridge University Press:  01 January 2021

Phebe Hong ,
Ameet Sarpatwari  and
Aaron S. Kesselheim
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Columns: Health Policy Portal
Information
Journal of Law, Medicine & Ethics , Volume 47 , Issue 2: Human Subject Protection , Summer 2019 , pp. 347 - 349
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Food and Drug Administration, Designating an Orphan Product: Drugs and Biological Products, July 26, 2018, available at <https://www.fda.gov/industry/developing-products-rare-diseases-conditions/designating-orphan-product-drugs-and-biological-products> (last visited April 28, 2019).+(last+visited+April+28,+2019).>Google Scholar
21 U.S.C. § 360cc(a) (2012).Google Scholar
21 C.F.R. § 316.3(b)(12) (2018).CrossRefGoogle Scholar
Food and Drug Administration, Bendeka Prescribing Information, available at <https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208194Orig1s000Lbl.pdf> (last visited May 3, 2019); Food and Drug Administration, Treanda Prescribing Information, available at <https://www.access-data.fda.gov/drugsatfda_docs/label/2008/022303lbl.pdf> (last visited May 3, 2019).+(last+visited+May+3,+2019);+Food+and+Drug+Administration,+Treanda+Prescribing+Information,+available+at++(last+visited+May+3,+2019).>Google Scholar
Food and Drug Administration, FDA Response re Certain Products Containing Bendamustine, February 20, 2019, available at <https://www.regulations.gov/document?D=FDA-2018-N-3773-0024> (last visited April 28, 2019).+(last+visited+April+28,+2019).>Google Scholar
Bendeka Prescribing Information, supra note 4.Google Scholar
Eagle Pharms., Inc. v. Azar, No. 16-790, ECF No. 64 (D.D.C. 2018).Google Scholar
Id.Google Scholar
FDA Reauthorization Act of 2017, Pub. L. No. 115-52, sec. 607(a), § 527(c)-(d), 131 Stat. 1005, 1049–50 (amending 21 U.S.C. § 360cc).Google Scholar
Certain Products Containing Bendamustine, supra note 5.Google Scholar
Teva Pharm., Annual Report (Form 10-K) (Mar. 26, 2019).Google Scholar
Certain Products Containing Bendamustine, supra note 5; Food and Drug Administration, Orphan Drug Designations and Approvals, available at <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/> (last visited April 28, 2019).+(last+visited+April+28,+2019).>Google Scholar